InvestorsHub Logo
Followers 120
Posts 19689
Boards Moderated 0
Alias Born 08/27/2005

Re: WeeZuhl post# 11998

Monday, 05/04/2020 1:35:48 PM

Monday, May 04, 2020 1:35:48 PM

Post# of 14689
@WeeZuhl, posted on another board but pertains to this company as well.
I'd like your assessment of this post.
---------------------------------------------------------------
With the herd already jumping over the gate.

Things are getting restless. Remdesivir will provide courage. But will the insurers pay for it? Other drugs?



"If the Brits are successful then the FDA should get that vaccine fast tracked over here ASAP"



But will they? What if the Chinese beats everyone to a vaccine?


The current vaccine debate centers around:

A study that says the virus can undergo recombination, and faster than a vaccine can be produced. More easily transmitted, and more virulent. Where this group says forget about a vaccine, and concentrate on drugs.

vs

A vaccine that has multiple "B-cell" epitopes. Where even if the virus mutates against a few, the remaining targets of the vaccine will still be there to stimulate immunity.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.